Chinese Herbal Drug Industry: Past, Present and Future | |
Lixin Zhang2,3,4; Wei Jia1 | |
2006 | |
出处 | Biotechnology Secondary Metabolites Plants and Microbes (Second Edition) |
出版地 | 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 |
出版者 | Taylor & Francis Group, LLC |
页码 | 417-444 |
英文摘要 | Instead of the hit-and-miss technology of the past, current biological research and a lot of drug discovery is being driven by the search for new molecules targeting disease-relevant proteins (Borisy et al., 2003; Shawver et al., 2002; Gibbs, 2000). In this approach, a specific protein is studied in vitro, in cells and in whole organisms, and evaluated as a drug target for a specific therapeutic indication (Gibbs, 2000; Lenz et al., 2000; Kalgutkar et al., 2000). The historical paradigm, 'one-drug-one-target dogma', has resulted in the identification of many effective chemical molecules that affect specific proteins, providing valuable reagents for both biology and medicine. One example is the recently FDA-approved drug Avastin, a recombinant humanized antibody designed to bind to and inhibit Vascular Endothelial Growth Factor (VEGF) in tumour angiogenesis (Nanda and St Croix, 2004). Benefiting from the advancement of biology and chemistry, the world market of drug products has increased tremendously over the past decade, from US $180 billion in 1990 to US $430 billion in 2001 (RGPI, 2002). IMS Health, a well-known information company of pharmaceutical industry, anticipated that the annual sales of drug products would reach US $587.9 billion by the year of 2005, with an average growth rate of 7.8%, much higher than the average growth rate of the global economy (2.4%) (RGPI, 2002). |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 专著章节 |
源URL | [http://ir.foo.ac.cn/handle/2SETSVCV/898] |
专题 | 中国科学院广州生物医药与健康研究院 |
作者单位 | 1.School of Pharmacy, Shanghai Jiao Tong University 2.SynerZ Pharmaceuticals Inc 3.Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences 4.Institute of Microbiology, Chinese Academy of Sciences |
推荐引用方式 GB/T 7714 | Lixin Zhang,Wei Jia. Chinese Herbal Drug Industry: Past, Present and Future. 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742:Taylor & Francis Group, LLC,2006:417-444. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论